Microlife Device Validation Table

 Download as PDF here.

Clinical Devices

Device

AAMI

BHS

ESH

Circumstance

Reference


Microlife BP 3AS1-2

Pass

At rest

1

Microlife WatchBP O3 (3MZ0)

Pass

At rest

2

Microlife WatchBP O3 (3MZ1)

Pass

At rest

3

Microlife WatchBP Office

Pass

At rest

4

Microlife WatchBP Office ABI

A/A

Pass

At rest

5

Pass

L-XL size cuff

4,6

Accuracy in assessing ABI

7

Accuracy in detecting Atrial Fibrillation

8,9

Microlife WatchBP Office AFIB

Pass

WatchBP Office Equivalence

4*

Accuracy in detecting Atrial Fibrillation

8, 9

Microlife WatchBP Office Target

Pass

BP A100 Equivalence

10*

 

Self-measurement devices

Device

AAMI

BHS

ESH

Circumstance

Reference


Microlife BP 3AC1-1

Pass

At rest

11

Pass

A/A

Pregnancy

12

Pass

B/A

Pre-eclampsia

12

Microlife BP 3AC1-1 PC

Pass

BP 3AC1-1 Equivalence

11*

Pass

ESRD population

13

Microlife BP 3AC1-2

Pass

BP 3AC1-1 Equivalence

11*

Microlife BP 3AG1

A/A

BP 3BT0-A Equivalence

14*

Microlife BP 3BTO-1

A/A

BP 3BT0-A Equivalence

14*

Microlife BP 3BTO-A

A/A

Small recruitment violation

14

Pass

A/B

Normotensive Pregnancy

15

Pass

B/B

Non-proteinuric HBP

15

Pass

A/B

Pre-Eclampsia

15

Microlife BP 3BTO-A(2)

A/A

BP 3BT0-A Equivalence

15*

Microlife BP 3BTO-AP

A/A

BP 3BT0-A Equivalence

14*

Microlife BP A100

Pass

BP A100 Plus Equivalence

10*

Microlife BP A100 Plus

Pass

With "M-L Size" Cuff

16

Pass

At rest

10

Pass

At rest

17

Microlife Exact BP (BP3MD1-3)

Pass

BP A100 Equivalence M-L cuff

16

Microlife RM 100

A/A

BP 3BT0-A Equivalence

14*

Microlife WatchBP Home (BP3MX1-1)

Pass

At rest

18

Pass

A/A

Pregnancy

19

Pass

A/A

Pre-eclampsia

19

Microlife WatchBP Home A (BP3MX1-3)

Pass

Watch BP Home Equivalence

18,19*

Accuracy in detecting Atrial Fibrillation

8,9

Microlife WatchBP Home N (BP3MX1-4)

Pass

Watch BP Home Equivalence

18,19*

Microlife WatchBP Home S (BP3MX1-5)

Pass

Watch BP Home Equivalence

18,19*

Accuracy in detecting Atrial Fibrillation

8,9

Microlife WatchBP O3 (3MZ0)

Pass

At rest

2

Microlife WatchBP O3 (3MZ1)

Pass

At rest

3

 

Wrist devices

Device

AAMI

BHS

ESH

Circumstance

Reference


Microlife BP W100

Pass

A/A

Pass

Supine position

20

Microlife BP W200-1

Pass

MAM averaging and supine position

21

* Indicates that the same validation applies to the device because of equivalence


Sources:

BHS - British Hypertension Society

dableducational Trust


Validation Protocols

 

BHS - British Hypertension Society

 

 

 

 

 

 

 

BHS A/A

 

 

 

 

 

 

BHS A/A - BHS Protocol

Microlife Blood Pressure Monitors are successfully validated according to the protocol of the BHS (British Hypertension Society). Microlife's upper automatic arm devices are validated with the highest possible grade of A/A.

 

 

 

BHS A/B

 

BHS A/B

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

European Society of Hypertension

 

 

 

 

 

 

 

 

ESH Protocol

 

Microlife Blood Pressure Monitors are successfully validated according to the International Protocol of the ESH (European Society of Hypertension).

 

 

 

 

 


 

Gütesiegel

Guetesiegel

It is the aim of the German Hypertension Society to improve measurement accuracy, by testing and awarding Blood Pressure Monitoring devices that fulfill its own test criteria following the strict protocol of the German Hypertension Society.

 


Publications


1.

de Greeff A, Nathan H, Stafford N, Liu B, Shennan AH. Development of an accurate oscillometric blood pressure device for low resource settings. Blood Press Monit 2008;13:342-8.

2.

Stergiou GS, Tzamouranis D, Nasothimiou EG, Karpettas N, Protogerou A. Are there really differences between home and daytime ambulatory blood pressure? Comparison using a novel dual-mode ambulatory and home monitor. J Hum Hypertens 2010;24:207-12.

3.

Ragazzo F, Saladini F, Palatini P. Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol. Blood Press Monit 2010;15:59-62.

4.

Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol. Blood Press Monit 2008;13:299-303.

5.

Saladini F, Benetti E, Masiero S, Palatini P. Accuracy of Microlife WatchBP Office ABI monitor assessed according to the 2002 European Society of Hypertension protocol and the British Hypertension Society protocol. Blood Press Monit 2011;16:258-61.

6.

Masiero S, Saladini F, Benetti E, Palatini P. Accuracy of the Microlife large-extra large-sized cuff (32-52 cm) coupled to an automatic oscillometric device. Blood Press Monit 2011;16:99-102.

7.

Kollias A, Xilomenos A, Protogerou A, Dimakakos E, Stergiou GS. Automated determination of the ankle-brachial index using an oscillometric blood pressure monitor: validation vs. Doppler measurement and cardiovascular risk factor profile. Hypertens Res 2011;34:825-30.

8.

Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009;22:848-52.

9.

Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M. Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009;23:654-8.

10.

Stergiou GS, Giovas PP, Neofytou MS, Adamopoulos DN. Validation of the Microlife BPA100 Plus device for self-home blood pressure measurement according to the International Protocol. Blood Press Monit 2006;11:157-60.

11.

Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG. Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1. Blood Press Monit 2005;10:325-31.

12.

de Greeff A, Reggiori F, Anthony J, Shennan A. The Microlife 3AC1: An accurate blood pressure measurement device in pregnancy and pre-eclampsia. J Hypertens 2006;24.

13.

Thompson AM, Eguchi K, Reznik ME, Shah SS, Pickering TG. Validation of an oscillometric home blood pressure monitor in an end-stage renal disease population and the effect of arterial stiffness on its accuracy. Blood Press Monit 2007;12:227-32.

14.

Cuckson AC, Reinders A, Shabeeh H, Shennan AH. Validation of the Microlife BP 3BTO-A oscillometric blood pressure monitoring device according to a modified British Hypertension Society protocol. Blood Press Monit 2002;7:319-24.

15.

Reinders A, Cuckson AC, Lee JT, Shennan AH. An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A. BJOG 2005;112:915-20.

16.

Bonso E, Dorigatti F, Palatini P. Accuracy of the BP A100 blood pressure measuring device coupled with a single cuff with standard-size bladder over a wide range of arm circumferences. Blood Press Monit 2009;14:216-9.

17.

Belghazi J, El Feghali RN, Moussalem T, Rejdych M, Asmar RG. Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension. Vasc Health Risk Manag 2007;3:389-400.

18.

Stergiou GS, Giovas PP, Gkinos CP, Patouras JD. Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol. Blood Press Monit 2007;12:185-8.

19.

Chung Y, de Greeff A, Shennan A. Validation and compliance of a home monitoring device in pregnancy: microlife WatchBP home. Hypertens Pregnancy 2009;28:348-59.

20.

Palatini P, Dorigatti F, Bonso E, Ragazzo F. Validation of Microlife BP W100 wrist device assessed according to the European Society of Hypertension and the British Hypertension Society protocols. Blood Press Monit 2009;14:41-4.

21.

Palatini P, Dorigatti F, Bonso E, Ragazzo F. Validation of the Microlife BP W200-1 wrist device for blood pressure measurement. Blood Press Monit 2008;13:295-8.

Font-size:
| |